Medscape Medical NewsAll articles

MR Diffusion Perfusion Mismatch V1.0

Olea Medical • Radiology • 01/13/2023

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

MR Diffusion Perfusion Mismatch V1.0 is an automated software tool designed to assist clinicians by processing MR diffusion and perfusion images to calculate parametric maps, segment volumes, and quantify mismatch regions. The device utilizes DICOM image processing, AI-driven segmentation, and 3D motion correction algorithms, functioning as a docker application on a technical platform to provide quantitative metrics for radiological assessment.

Summary

MR Diffusion Perfusion Mismatch V1.0 is an automatic image processing software tool designed for radiology applications. Its core function is to assist trained radiologists and surgeons by processing MR Diffusion-weighted imaging (DWI) and MR Perfusion-weighted imaging (PWI) data to compute parametric maps, extract volumes of interest based on numerical thresholds, and automatically calculate the mismatch between these volumes. The software operates as a docker application that integrates with a separate Medical Image Communications Device (MICD) platform, which manages DICOM image input, output, and visualization, as the tool itself lacks a direct interface. It is intended as an adjunctive tool to be used with other patient information and professional judgment, not for standalone diagnosis, and it does not alter the original medical images. The device employs a 3D rigid motion correction algorithm and utilizes AI algorithms for its Diffusion Brain Extraction Tool (BET) and Perfusion Background Segmentation. Comparative performance testing against its predicate (Olea Sphere V3.0) showed statistical equivalence for several parametric maps (ADC, CBF, CBV, MTT, tMIP), while TTP and Tmax maps, though not statistically equivalent due to acquisition sensitivities, were deemed qualitatively equivalent by a neuroradiologist. Segmented volumes (Volume_1, Volume_2) and various mismatch metrics (Ratio, Volume, Relative Mismatch) demonstrated acceptable biases and differences, falling within expected inter-software variability and considered visually or clinically acceptable by a neuroradiologist.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

MR Diffusion (DWI)MR Perfusion (PWI)Mismatch ComputationParametric MapsImage Processing SoftwareRadiology Assessment AidDICOM Data ProcessingVolume of Interest SegmentationAI AlgorithmsMotion Correction (3D)

Device Metadata

Submission Number
K223502
Company
Olea Medical
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How do the specific AI algorithms for Brain Extraction Tool and Perfusion Background Segmentation in MR Diffusion Perfusion Mismatch V1.0 handle variations in image quality or atypical anatomies compared to the predicate's methods?; Given the sensitivity of TTP and Tmax maps to acquisition parameters, what specific MRI acquisition protocols or preprocessing steps are recommended to optimize the reliability of these temporal maps generated by the device?; What is the quantifiable impact of the 3D rigid motion correction algorithm on the accuracy of derived parametric maps and mismatch volumes in clinical scenarios with varying degrees of patient motion?; Beyond the statistical and qualitative equivalence reported, are there specific clinical scenarios or patient subgroups where the differences in TTP, Tmax, or Volume_2 calculations between V1.0 and its predicate might lead to differing interpretations?; What are the validation data supporting the performance of the AI-based segmentation across different MR scanner vendors and field strengths, and how does the device ensure robustness in diverse clinical settings?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score15/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, bias, preprocessing)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(docker)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
MR Diffusion Perfusion Mismatch V1.0 - Olea Medical | ESL FDA AI Device Intelligence